Intellipharmaceutics Announces 2013 Year End Results

[GlobeNewswire] – TORONTO — Intellipharmaceutics International Inc. , a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral … more

View todays social media effects on IPCI

View the latest stocks trending across Twitter. Click to view dashboard

See who Intellipharmaceutics is hiring next, click here to view